| 序号 | 股票代码 | 股票名称 | 机构名称 | 变动方向 | 变动股份数(股) | 变动后数量(股) | 变动后持股率 | 公布日期 |
| 201 | 06826 | 昊海生物科技 | Prudence Investment Management (Hong Kong) Limited |
增持 | 2.00万 | 362.01万 | 9.04% | 2020-05-29 |
| 202 | 06826 | 昊海生物科技 | Morgan Stanley |
减持 | -11.79万 | 194.46万 | 4.85% | 2020-04-15 |
| 203 | 06826 | 昊海生物科技 | Morgan Stanley |
减持 | -30.29万 | 225.62万 | 5.63% | 2020-04-09 |
| 204 | 06826 | 昊海生物科技 | Dalton Investments LLC |
减持 | -6.05万 | 237.18万 | 5.92% | 2020-04-07 |
| 205 | 06826 | 昊海生物科技 | The Bank of New York Mellon Corporation |
减持 | -90.12万 | 164.74万 | 4.11% | 2020-04-03 |
| 206 | 06826 | 昊海生物科技 | The Bank of New York Mellon Corporation |
增持 | 80.50万 | 254.86万 | 6.36% | 2020-04-02 |
| 207 | 06826 | 昊海生物科技 | Morgan Stanley |
减持 | -13.47万 | 268.26万 | 6.69% | 2020-04-01 |
| 208 | 06826 | 昊海生物科技 | UBS Group AG |
减持 | -2.30万 | 319.09万 | 7.97% | 2020-03-25 |
| 209 | 06826 | 昊海生物科技 | UBS Group AG |
增持 | 5.00万 | 322.25万 | 8.05% | 2020-03-24 |
| 210 | 06826 | 昊海生物科技 | UBS Group AG |
减持 | -2.30万 | 318.79万 | 7.96% | 2020-02-13 |
| 211 | 06826 | 昊海生物科技 | UBS Group AG |
增持 | 7.44万 | 322.50万 | 8.05% | 2020-02-12 |
| 212 | 06826 | 昊海生物科技 | Prudence Investment Management (Hong Kong) Limited |
减持 | -1.65万 | 360.27万 | 8.99% | 2020-01-15 |
| 213 | 06826 | 昊海生物科技 | UBS Group AG |
减持 | -4.90万 | 316.07万 | 7.89% | 2019-11-29 |
| 214 | 06826 | 昊海生物科技 | UBS Group AG |
增持 | 4.90万 | 321.17万 | 8.02% | 2019-11-26 |
| 215 | 06826 | 昊海生物科技 | Matthews International Capital Management, LLC |
减持 | -4.99万 | 196.50万 | 4.90% | 2019-11-20 |
| 216 | 06826 | 昊海生物科技 | Matthews International Capital Management, LLC |
减持 | -20.36万 | 224.25万 | 5.59% | 2019-11-12 |
| 217 | 06826 | 昊海生物科技 | Dalton Investments LLC |
增持 | 20.43万 | 248.43万 | 6.20% | 2019-11-12 |
| 218 | 06826 | 昊海生物科技 | Matthews International Capital Management, LLC |
减持 | -44.73万 | 247.82万 | 6.18% | 2019-11-06 |
| 219 | 06826 | 昊海生物科技 | Dalton Investments LLC |
增持 | 26.11万 | 219.18万 | 5.47% | 2019-11-05 |
| 220 | 06826 | 昊海生物科技 | PRIME CAPITAL MANAGEMENT COMPANY LIMITED |
减持 | -1.93万 | 518.61万 | 12.95% | 2019-10-31 |
| 221 | 06826 | 昊海生物科技 | Matthews International Capital Management, LLC |
增持 | 9.05万 | 327.55万 | 8.17% | 2019-10-18 |
| 222 | 06826 | 昊海生物科技 | Matthews International Capital Management, LLC |
减持 | -5.89万 | 318.50万 | 7.95% | 2019-10-17 |
| 223 | 06826 | 昊海生物科技 | Templeton Investment Counsel, LLC |
增持 | 14.93万 | 286.94万 | 7.17% | 2019-09-30 |
| 224 | 06826 | 昊海生物科技 | Templeton Investment Counsel, LLC |
减持 | -12.65万 | 272.01万 | 6.79% | 2019-09-26 |
| 225 | 06826 | 昊海生物科技 | UBS Group AG |
减持 | -1.60万 | 320.10万 | 7.99% | 2019-07-23 |
| 226 | 06826 | 昊海生物科技 | PRIME CAPITAL MANAGEMENT COMPANY LIMITED |
减持 | -2.12万 | 558.36万 | 13.94% | 2019-07-03 |
| 227 | 06826 | 昊海生物科技 | UBS Group AG |
减持 | -10.14万 | 358.80万 | 8.96% | 2019-06-21 |
| 228 | 06826 | 昊海生物科技 | Morgan Stanley |
增持 | 6.41万 | 283.84万 | 7.08% | 2019-06-20 |
| 229 | 06826 | 昊海生物科技 | PRIME CAPITAL MANAGEMENT COMPANY LIMITED |
减持 | -3.10万 | 597.97万 | 14.93% | 2019-06-19 |
| 230 | 06826 | 昊海生物科技 | Matthews International Capital Management, LLC |
增持 | 2.56万 | 361.99万 | 9.03% | 2019-04-23 |
| 231 | 06826 | 昊海生物科技 | Templeton Investment Counsel, LLC |
减持 | -4.84万 | 320.11万 | 7.99% | 2019-04-10 |
| 232 | 06826 | 昊海生物科技 | Matthews International Capital Management, LLC |
减持 | -3.99万 | 358.96万 | 8.96% | 2019-04-09 |
| 233 | 06826 | 昊海生物科技 | UBS Group AG |
减持 | -10.00万 | 395.71万 | 9.88% | 2019-03-25 |
| 234 | 06826 | 昊海生物科技 | Templeton Investment Counsel, LLC |
减持 | -17.52万 | 354.17万 | 8.84% | 2019-03-15 |
| 235 | 06826 | 昊海生物科技 | Matthews International Capital Management, LLC |
减持 | -3.95万 | 399.62万 | 9.97% | 2019-01-14 |
| 236 | 06826 | 昊海生物科技 | UBS Group AG |
增持 | 104.14万 | 404.29万 | 10.10% | 2018-12-17 |
| 237 | 06826 | 昊海生物科技 | Matthews International Capital Management, LLC |
减持 | -4.30万 | 438.90万 | 10.96% | 2018-11-19 |
| 238 | 06826 | 昊海生物科技 | Prudence Investment Management (Hong Kong) Limited |
减持 | -1.04万 | 400.34万 | 9.99% | 2018-08-21 |
| 239 | 06826 | 昊海生物科技 | Morgan Stanley |
增持 | 2.61万 | 240.85万 | 6.01% | 2018-07-30 |
| 240 | 06826 | 昊海生物科技 | Matthews International Capital Management, LLC |
增持 | 7.14万 | 484.79万 | 12.10% | 2018-06-20 |
| 241 | 06826 | 昊海生物科技 | Prudence Investment Management (Hong Kong) Limited |
增持 | 2.00万 | 400.73万 | 10.01% | 2018-06-05 |
| 242 | 06826 | 昊海生物科技 | Prudence Investment Management (Hong Kong) Limited |
减持 | -9900.00 | 399.81万 | 9.98% | 2018-05-10 |
| 243 | 06826 | 昊海生物科技 | Matthews International Capital Management, LLC |
增持 | 3.10万 | 442.35万 | 11.04% | 2018-05-08 |
| 244 | 06826 | 昊海生物科技 | UBS Group AG |
增持 | 1300.00 | 294.48万 | 7.35% | 2018-05-03 |
| 245 | 06826 | 昊海生物科技 | Morgan Stanley |
增持 | 5.52万 | 205.11万 | 5.12% | 2018-04-12 |
| 246 | 06826 | 昊海生物科技 | UBS Group AG |
减持 | -10.95万 | 320.29万 | 7.99% | 2018-04-03 |
| 247 | 06826 | 昊海生物科技 | Morgan Stanley |
减持 | -2.25万 | 199.23万 | 4.97% | 2018-03-28 |
| 248 | 06826 | 昊海生物科技 | Morgan Stanley |
增持 | 6.76万 | 201.48万 | 5.03% | 2018-03-27 |
| 249 | 06826 | 昊海生物科技 | Matthews International Capital Management, LLC |
增持 | 2.92万 | 401.96万 | 10.03% | 2018-03-16 |
| 250 | 06826 | 昊海生物科技 | UBS Group AG |
增持 | 3900.00 | 328.35万 | 8.20% | 2018-02-20 |
